Annual Cash & Cash Equivalents
$135.55 M
+$69.22 M+104.36%
December 31, 2023
Summary
- As of February 7, 2025, CORT annual cash & cash equivalents is $135.55 million, with the most recent change of +$69.22 million (+104.36%) on December 31, 2023.
- During the last 3 years, CORT annual cash & cash equivalents has risen by +$59.36 million (+77.91%).
- CORT annual cash & cash equivalents is now at all-time high.
Performance
CORT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$137.29 M
+$8.70 M+6.77%
September 30, 2024
Summary
- As of February 7, 2025, CORT quarterly cash and cash equivalents is $137.29 million, with the most recent change of +$8.70 million (+6.77%) on September 30, 2024.
- Over the past year, CORT quarterly cash and cash equivalents has dropped by -$12.46 million (-8.32%).
- CORT quarterly cash and cash equivalents is now -54.23% below its all-time high of $299.94 million, reached on March 31, 2023.
Performance
CORT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CORT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +104.4% | -8.3% |
| 3 y3 years | +77.9% | +107.0% |
| 5 y5 years | +225.7% | +107.0% |
CORT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +104.4% | -54.2% | +288.4% |
| 5 y | 5-year | at high | +333.5% | -54.2% | +349.2% |
| alltime | all time | at high | +3452.2% | -54.2% | +9623.0% |
Corcept Therapeutics Incorporated Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $137.29 M(+6.8%) |
| Jun 2024 | - | $128.59 M(-14.1%) |
| Mar 2024 | - | $149.75 M(+10.5%) |
| Dec 2023 | $135.55 M(+104.4%) | $135.55 M(+21.2%) |
| Sep 2023 | - | $111.80 M(-35.1%) |
| Jun 2023 | - | $172.38 M(-42.5%) |
| Mar 2023 | - | $299.94 M(+352.2%) |
| Dec 2022 | $66.33 M(-14.5%) | $66.33 M(+32.0%) |
| Sep 2022 | - | $50.24 M(+42.1%) |
| Jun 2022 | - | $35.35 M(-42.9%) |
| Mar 2022 | - | $61.86 M(-20.3%) |
| Dec 2021 | $77.62 M(+1.9%) | $77.62 M(-18.0%) |
| Sep 2021 | - | $94.69 M(-0.8%) |
| Jun 2021 | - | $95.43 M(+82.2%) |
| Mar 2021 | - | $52.38 M(-31.2%) |
| Dec 2020 | $76.19 M(+143.7%) | $76.19 M(+149.3%) |
| Sep 2020 | - | $30.56 M(-47.8%) |
| Jun 2020 | - | $58.52 M(-30.7%) |
| Mar 2020 | - | $84.48 M(+170.2%) |
| Dec 2019 | $31.27 M(-24.9%) | $31.27 M(-30.4%) |
| Sep 2019 | - | $44.95 M(-22.7%) |
| Jun 2019 | - | $58.14 M(+17.1%) |
| Mar 2019 | - | $49.65 M(+19.3%) |
| Dec 2018 | $41.63 M(+34.0%) | $41.63 M(+22.8%) |
| Sep 2018 | - | $33.89 M(+8.8%) |
| Jun 2018 | - | $31.16 M(-5.9%) |
| Mar 2018 | - | $33.12 M(+6.6%) |
| Dec 2017 | $31.06 M(-39.7%) | $31.06 M(+0.0%) |
| Sep 2017 | - | $31.06 M(-7.6%) |
| Jun 2017 | - | $33.62 M(-11.5%) |
| Mar 2017 | - | $37.98 M(-26.3%) |
| Dec 2016 | $51.54 M(+27.5%) | $51.54 M(+7.7%) |
| Sep 2016 | - | $47.87 M(+14.5%) |
| Jun 2016 | - | $41.79 M(+2.6%) |
| Mar 2016 | - | $40.74 M(+0.8%) |
| Dec 2015 | $40.44 M(+66.8%) | $40.44 M(+10.9%) |
| Sep 2015 | - | $36.45 M(-1.6%) |
| Jun 2015 | - | $37.05 M(-2.4%) |
| Mar 2015 | - | $37.95 M(+56.5%) |
| Dec 2014 | $24.25 M | $24.25 M(-9.5%) |
| Sep 2014 | - | $26.78 M(-21.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $33.97 M(-22.1%) |
| Mar 2014 | - | $43.62 M(-20.5%) |
| Dec 2013 | $54.88 M(-41.0%) | $54.88 M(-13.1%) |
| Sep 2013 | - | $63.17 M(-12.5%) |
| Jun 2013 | - | $72.22 M(-11.3%) |
| Mar 2013 | - | $81.46 M(-12.4%) |
| Dec 2012 | $93.03 M(+134.7%) | $93.03 M(-8.5%) |
| Sep 2012 | - | $101.63 M(+191.2%) |
| Jun 2012 | - | $34.90 M(-18.1%) |
| Mar 2012 | - | $42.63 M(+7.5%) |
| Dec 2011 | $39.63 M(+61.3%) | $39.63 M(-13.7%) |
| Sep 2011 | - | $45.91 M(-12.1%) |
| Jun 2011 | - | $52.23 M(-11.8%) |
| Mar 2011 | - | $59.20 M(+140.9%) |
| Dec 2010 | $24.58 M(+3.0%) | $24.58 M(-30.5%) |
| Jun 2010 | - | $35.38 M(+90.8%) |
| Mar 2010 | - | $18.55 M(-22.3%) |
| Dec 2009 | $23.87 M(+62.2%) | $23.87 M(+122.7%) |
| Sep 2009 | - | $10.72 M(-25.8%) |
| Jun 2009 | - | $14.45 M(-24.7%) |
| Mar 2009 | - | $19.19 M(+30.4%) |
| Dec 2008 | $14.72 M(+28.7%) | $14.72 M(-9.8%) |
| Sep 2008 | - | $16.32 M(-37.5%) |
| Jun 2008 | - | $26.12 M(-17.8%) |
| Mar 2008 | - | $31.79 M(+178.1%) |
| Dec 2007 | $11.43 M(+28.4%) | $11.43 M(-38.4%) |
| Sep 2007 | - | $18.57 M(+55.4%) |
| Jun 2007 | - | $11.95 M(-19.0%) |
| Mar 2007 | - | $14.74 M(+65.6%) |
| Dec 2006 | $8.91 M(+133.4%) | $8.91 M(+170.2%) |
| Sep 2006 | - | $3.30 M(-13.7%) |
| Jun 2006 | - | $3.82 M(+79.1%) |
| Mar 2006 | - | $2.13 M(-44.1%) |
| Dec 2005 | $3.82 M(-35.6%) | $3.82 M(+170.3%) |
| Sep 2005 | - | $1.41 M(-50.0%) |
| Jun 2005 | - | $2.83 M(-19.3%) |
| Mar 2005 | - | $3.50 M(-41.0%) |
| Dec 2004 | $5.93 M | $5.93 M(-73.1%) |
| Sep 2004 | - | $22.02 M(-37.5%) |
| Jun 2004 | - | $35.24 M(+291.8%) |
| Mar 2004 | - | $8.99 M |
FAQ
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly cash and cash equivalents year-on-year change?
What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of CORT is $135.55 M
What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash & cash equivalents is $135.55 M
What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, CORT annual cash & cash equivalents has changed by +$69.22 M (+104.36%)
What is Corcept Therapeutics Incorporated quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CORT is $137.29 M
What is the all time high quarterly cash and cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash and cash equivalents is $299.94 M
What is Corcept Therapeutics Incorporated quarterly cash and cash equivalents year-on-year change?
Over the past year, CORT quarterly cash and cash equivalents has changed by -$12.46 M (-8.32%)